These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36004342)

  • 1. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
    Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
    Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire.
    Nelson LM; Forsythe A; McLeod L; Pulgar S; Maldonado M; Coles T; Zhang Y; Webb SM; Badia X
    Patient; 2013; 6(2):113-24. PubMed ID: 23575965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of quality of life in 102 patients with treated Cushing's disease.
    Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.
    van der Pas R; de Bruin C; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Webb SM; Lamberts SW; Hofland LJ; Feelders RA
    Pituitary; 2013 Dec; 16(4):536-44. PubMed ID: 23225121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
    Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?
    Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR
    Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle cognitive impairments in patients with long-term cure of Cushing's disease.
    Tiemensma J; Kokshoorn NE; Biermasz NR; Keijser BJ; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2699-714. PubMed ID: 20371667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.
    Psaras T; Milian M; Hattermann V; Will BE; Tatagiba M; Honegger J
    J Endocrinol Invest; 2011; 34(7):e168-77. PubMed ID: 21060251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
    Valassi E; Feelders R; Maiter D; Chanson P; Yaneva M; Reincke M; Krsek M; Tóth M; Webb SM; Santos A; Paiva I; Komerdus I; Droste M; Tabarin A; Strasburger CJ; Franz H; Trainer PJ; Newell-Price J; Wass JA; Papakokkinou E; Ragnarsson O;
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):787-798. PubMed ID: 29574994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
    Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
    Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
    Lacroix A; Bronstein MD; Schopohl J; Delibasi T; Salvatori R; Li Y; Barkan A; Suzaki N; Tauchmanova L; Ortmann CE; Ravichandran S; Petersenn S; Pivonello R
    J Endocrinol Invest; 2020 Nov; 43(11):1613-1622. PubMed ID: 32385851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission.
    Ragnarsson O; Berglund P; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1640-8. PubMed ID: 22761462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life impairment after a diagnosis of Cushing's syndrome.
    Webb SM; Valassi E
    Pituitary; 2022 Oct; 25(5):768-771. PubMed ID: 35767164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life in Cushing's disease: A long term issue?
    Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E
    Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission.
    Feldkamp L; Müller L; Deutschbein T; Detomas M; Hahner S; Strasburger CJ; Künzel H; Oßwald A; Braun L; Rubinstein G; Reincke M; Quinkler M; Kienitz T
    Eur J Endocrinol; 2023 Apr; 188(4):366-374. PubMed ID: 36995896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between physical activity, sleep, and quality of life in patients in bio-chemical remission from Cushing's syndrome.
    Moyers SA; Tiemensma J
    Qual Life Res; 2020 Aug; 29(8):2089-2100. PubMed ID: 32221806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease.
    van der Werff SJ; Andela CD; Nienke Pannekoek J; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; Pereira AM; van der Wee NJ
    Neuroimage Clin; 2014; 4():659-67. PubMed ID: 24936417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral adrenalectomy in Cushing's disease: Altered long-term quality of life compared to other treatment options.
    Sarkis P; Rabilloud M; Lifante JC; Siamand A; Jouanneau E; Gay E; Chaffanjon P; Chabre O; Raverot G
    Ann Endocrinol (Paris); 2019 Feb; 80(1):32-37. PubMed ID: 30243473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.